JHSM
Journal of Health Sciences and Medicine

Journal of Health Sciences and Medicine (JHSM) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

ISSN: Active
eISSN: 2636-8579
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
The relationship between levels of apolipoprotein A1 and B in aqueous and serum with stage of diabetic retinopathy
Abstract
Aims: To determine the association between serum and aqueous apolipoprotein (Apo) A1 and Apo B levels and Apo B/A1 ratio in diabetic retinopathy. Material and Method: This cross-sectional prospective study included 63 diabetic patients with or without retinopathy and 38 control subjects who underwent cataract surgery. The study groups were as follows; healthy subjects (Group 1), diabetic patients without retinopathy (Group 2), with non-proliferative diabetic retinopathy (Group 3), and with proliferative diabetic retinopathy (Group 4). Serum and aqueous Apo A1 and Apo B levels were determined by using an enzyme-linked immunosorbent assay. Results: The amount of Apo B was determined in aqueous samples of all (100%) patients in Group 4 and 77.7% of patients in Group 3.The mean serum Apo B/A1 ratio was significantly higher in Group 2, Group 3 and Group 4 compared with Group 1 (p=0.002, p=0.037 and p<0.001, respectively). The aqueous Apo B level, aqueous and serum Apo B/A1 levels were significantly correlated with the severity of retinopathy in diabetic patients (all p<0.001). Conclusion: Higher serum and aqueous Apo B/A1 ratio were significantly associated with the stage of diabetic retinopathy.

Keywords : Aqueous humor, apolipoprotein A1, apolipoprotein B, diabetic retinopathy

Download Article


1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet2010 Jul 10; 376: 124-36.
2. Vujosevic S, Aldington SJ, Silva P, et al. Screening for diabeticretinopathy: new perspectives and challenges. Lancet DiabetesEndocrinol 2020; 8: 337-47.
3. Ghamdi AHA. Clinical predictors of diabetic retinopathyprogression; a systematic review. Curr Diabetes Rev 2020; 16:242-7.
4. Lyons TJ, Jenkins AJ, Zheng D, et al. Diabetic retinopathy andserum lipoprotein subclasses in the DCCT/EDIC cohort. InvestOphthalmol Vis Sci 2004; 45: 910-8.
5. Klein R, Sharrett AR, Klein BE, et al. The association ofatherosclerosis, vascular risk factors, and retinopathy in adultswith diabetes: the Atherosclerosis Risk in Communities Study.Ophthalmology 2002; 109: 1225-34.
6. Zhou Y, Wang C, Shi K, YinX. Relationship between dyslipidemiaand diabetic retinopathy: A systematic review and meta-analysis.Medicine (Baltimore) 2018; 97: e12283.
7. Zhang Q, Hu J, Hu Y, et al. Relationship between serumapolipoproteins levels and retinopathy risk in subjects with type 2diabetes mellitus. Acta Diabetol 2018; 55: 681-9.
8. Simo R, Garcia-Ramirez M, Higuera M, Hernandez C.Apolipoprotein A1 is overexpressed in the retina of diabeticpatients. Am J Ophthalmol 2009; 147: 319-25 e1.
9. Simo R, Higuera M, Garcia-Ramirez M, Canals F, Garcia-Arumi J,Hernandez C. Elevation of apolipoprotein A-I and apolipoproteinH levels in the vitreous fluid and overexpression in the retina ofdiabetic patients. Arch Ophthalmol 2008; 126: 1076-81.
10. Davidson MH. Apolipoprotein measurements: is more widespreaduse clinically indicated? Clin Cardiol 2009; 32: 482-6.
11. Shah PK, Kaul S, Nilsson J, Cercek B. Exploiting thevascular protective effects of high-density lipoprotein and itsapolipoproteins: an idea whose time for testing is coming, part II.Circulation 2001; 104: 2498-502.
12. Marcovina S, Packard CJ. Measurement and meaning ofapolipoprotein AI and apolipoprotein B plasma levels. J InternMed 2006; 259: 437-46.
13. Wu M, Chen Y, Wilson K, et al. Intraretinal leakage and oxidationof LDL in diabetic retinopathy. Invest OphthalmolVis Sci 2008;49: 2679-85.
14. Hu A, Luo Y, Li T, et al. Low serum apolipoprotein A1/B ratiois associated with proliferative diabetic retinopathy in type 2diabetes. Graefes Arch Clin Exp Ophthalmol 2012; 250: 957-62.
15. Sasongko MB, Wong TY, Nguyen TT, et al. Serum apolipoproteinAI and B are stronger biomarkers of diabetic retinopathy thantraditional lipids. Diabetes Care 2011; 34: 474-9.
16. Sasongko MB, Wong TY, Nguyen TT, et al. Serum apolipoproteinsare associated with systemic and retinal microvascular function inpeople with diabetes. Diabetes 2012; 61: 1785-92.
17. Ankit BS, Mathur G, Agrawal RP, Mathur KC. Strongerrelationship of serum apolipoprotein A-1 and B with diabeticretinopathy than traditional lipids. Indian J Endocrinol Metab2017; 21: 102-5.
18. Chung JO, Park SY, Cho DH, Chung DJ, Chung MY. Associationsbetween serum apolipoproteins, urinary albumin excretion rate,estimated glomerular filtration rate, and diabetic retinopathy inindividuals with type 2 diabetes. Medicine (Baltimore) 2019; 98:e15703.
19. Early Treatment Diabetic Retinopathy Study Research Group.Grading diabetic retinopathy from stereoscopic color fundusphotographs&mdash;an extension of the modified Airlie Houseclassification: ETDRS report number 10: Early Treatment DiabeticRetinopathy Study Research Group. Ophthalmology 1991; 98:786-806.
20. Funatsu H, Yamashita H, Noma H, et al. Aqueous humor levels ofcytokines are related to vitreous levels and progression of diabeticretinopathy in diabetic patients. Graef Arch Clin Exp Ophthalmol2005; 243: 3-8.
21. Barsotti MF, Bartels SP, Freddo TF, Kamm RD. The source ofprotein in the aqueous humor of the normal monkey eye. InvestOphthalmol Vis Sci 1992; 33: 581-95.
22. Maurice DM. Flow of water between aqueous and vitreouscompartments in the rabbit eye. Am J Physiol 1987; 252: F104-8.
23. Fatt I. Flow and diffusion in the vitreous body of the eye. BullMath Biol 1975; 37: 85-90.
24. Kawai S, Nakajima T, Hokari S, Komoda T, Kawai K.Apolipoprotein A-I concentration in tears in diabetic retinopathy.Annals Clin Bioch 2002; 39: 56-61.
25. Garcia-Ramirez M, Canals F, Hernandez C, et al. Proteomicanalysis of human vitreous fluid by fluorescence-based differencegel electrophoresis (DIGE): a new strategy for identifyingpotential candidates in the pathogenesis of proliferative diabeticretinopathy. Diabetologia 2007; 50: 1294-303.
26. Crosby-Nwaobi R, Chatziralli I, Sergentanis T, Dew T, ForbesA, Sivaprasad S. Cross Talk between Lipid Metabolism andInflammatory Markers in Patients with Diabetic Retinopathy. JDiabetes Res 2015; 2015: 191382.
27. Miljanovic B, Glynn RJ, Nathan DM, Manson JE, SchaumbergDA. A prospective study of serum lipids and risk of diabeticmacular edema in type 1 diabetes. Diabetes 2004; 53: 2883-92.
28. Keech AC, Mitchell P, Summanen PA, et al. Effect of fenofibrateon the need for laser treatment for diabetic retinopathy (FIELDstudy): a randomised controlled trial. Lancet 2007; 370: 1687-97.
29. Tserentsoodol N, Sztein J, Campos M, et al. Uptake of cholesterolby the retina occurs primarily via a low density lipoproteinreceptor-mediated process. Molecular Vision 2006; 12: 1306-18.
30. Tserentsoodol N, Gordiyenko NV, Pascual I, Lee JW, Fliesler SJ,Rodriguez IR. Intraretinal lipid transport is dependent on highdensity lipoprotein-like particles and class B scavenger receptors.Molecular vision 2006; 12: 1319-33.
31. Chiang SY, Tsai ML, Wang CY, et al. Proteomic analysis andidentification of aqueous humor proteins with a pathophysiologicalrole in diabetic retinopathy. J Proteomics 2012; 75: 2950-9.
Article available in :
Volume 6, Issue 2, 2023
Page : 546-551
https://doi.org/10.32322/jhsm.1253299
Article Information
Received : 21 Şub 2023
Accepted : 21 Mar 2023
Published : 27 Mar 2023
Corresponding Author :

İnci Elif Erbahçeci Timur: Department of Ophthalmology, Ankara City Hospital, Ministry of Health, Ankara, Turkey

[email protected]
Citation : Erbahçeci Timur İE, Örnek K, Çağlayan O. The relationship between levels of apolipoprotein A1 and B in aqueous and serum with stage of diabetic retinopathy. J Health Sci Med 2023; 6(2): 546-551.

Read: 240
Cited: 0
Download : 120
_Footer